Similar Posts
What Higher Ed Can Learn From Health Care
BypeterCheck out my recent interview with The Chronicle of Higher Education about the rising costs of education and healthcare: For decades, higher education has come under public scrutiny for rising costs. But there is at least one other sector that seems to feel even more heat from policy makers and ire from the public. That…
Does Your Oncologist Care About Your Quality of Life?
ByadminFacing advanced cancer, who among us wouldn’t look to our oncologist for expert advice on whether another round of chemotherapy makes sense? But do you know what your oncologist cares about, and can you be sure her recommendations map onto your own treatment preferences? … (Read the rest and view comments at Critical Decisions)
Coverage That Kills – Breast Cancer Care Is Undermined By High Deductible Health Plans
Byadmin2Here is an awful thing about high deductible health plans: They delay breast cancer diagnosis and get in the way of proper breast cancer care.
Do patients need the numbers?
Byadmin
An interesting article by Peter Schwartz in the latest Hastings Center Report on whether patients, facing difficult medical decisions, ought to get precise numbers on the risks and benefits of their alternatives. I contributed a commentary, urging researchers to keep developing better ways to help patients make rational use of the numbers.Compared to what?
ByadminRisk isn’t all it is cracked up to be, as Amanda Dillard argues (with me as a co-author) in a new paper available on line at the Annals of Behavioral Medicine. At high risk for breast cancer? May not matter, in terms of getting you interested in taking a pill to reduce that risk. But FEELING at high risk? That is a different story. As Amanda shows quite persuasively, after you control (statistically speaking) for women’s actual risk, it is the way they feel about that risk that determines their behavior.
Deciding About Breast Cancer Chemotherapy
ByadminAs if being diagnosed with breast cancer wasn’t bad enough, many women with this diagnosis face complicated decisions about what kind of medicine or chemotherapy to take, if any, to reduce their chance of cancer recurrence. As I discussed in a recent post, the mathematics of such decisions can be hard to comprehend for many patients. …
